Invictus MD (TSXV:IMH) (OTC:IVITF) (FRA:8IS1) Announces Phase II Construction Update
INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV:IMH) (OTC:IVITF) (FRA:8IS1) is pleased to announce that construction of the Phase 2 development, a purpose built, multiple room production facility, is well underway at its wholly owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), a licensed producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
The foundation for the Phase 2 facility has been poured and the exterior is expected to be completed by the first part of November 2017. By the end of January 2018, the interior fit-out is expected.
For more information head over to www.DailyMarijuanaObserver.com